358 related articles for article (PubMed ID: 17928059)
21. MicroRNA therapeutics: a new niche for antisense nucleic acids.
Hammond SM
Trends Mol Med; 2006 Mar; 12(3):99-101. PubMed ID: 16473043
[TBL] [Abstract][Full Text] [Related]
22. [Micro-RNA and oncogenesis].
Bénard J; Douc-Rasy S
Bull Cancer; 2005 Sep; 92(9):757-62. PubMed ID: 16203264
[TBL] [Abstract][Full Text] [Related]
23. siRNA for gene silencing: a route to drug target discovery.
Jones SW; Souza PM; Lindsay MA
Curr Opin Pharmacol; 2004 Oct; 4(5):522-7. PubMed ID: 15351359
[TBL] [Abstract][Full Text] [Related]
24. RNA interference for therapy in the vascular endothelium.
Kaufmann J; Ahrens K; Santel A
Microvasc Res; 2010 Sep; 80(2):286-93. PubMed ID: 20144624
[TBL] [Abstract][Full Text] [Related]
25. Antiviral applications of RNAi.
Morris KV; Rossi JJ
Curr Opin Mol Ther; 2006 Apr; 8(2):115-21. PubMed ID: 16610763
[TBL] [Abstract][Full Text] [Related]
26. Viral vector-mediated RNA interference.
Couto LB; High KA
Curr Opin Pharmacol; 2010 Oct; 10(5):534-42. PubMed ID: 20620113
[TBL] [Abstract][Full Text] [Related]
27. miRNA, piRNA, siRNA -- Kleine Wiener Ribonukleinsäuren.
Grosshans H; Svoboda P
Bioessays; 2007 Sep; 29(9):940-3. PubMed ID: 17688276
[No Abstract] [Full Text] [Related]
28. RNA interference based gene therapy for neurological disease.
Jagannath A; Wood M
Brief Funct Genomic Proteomic; 2007 Mar; 6(1):40-9. PubMed ID: 17478451
[TBL] [Abstract][Full Text] [Related]
29. Target site effects in the RNA interference and microRNA pathways.
Obernosterer G; Tafer H; Martinez J
Biochem Soc Trans; 2008 Dec; 36(Pt 6):1216-9. PubMed ID: 19021528
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA epigenetic alterations: predicting biomarkers and therapeutic targets in human diseases.
Wang Y; Liang Y; Lu Q
Clin Genet; 2008 Oct; 74(4):307-15. PubMed ID: 18713257
[TBL] [Abstract][Full Text] [Related]
31. RNA interference: a novel and physiologic mechanism of gene silencing with great therapeutic potential.
Calderón AJ; Lavergne JA
P R Health Sci J; 2005 Mar; 24(1):27-33. PubMed ID: 15895874
[TBL] [Abstract][Full Text] [Related]
32. Review article: RNA interference--potential therapeutic applications for the gastroenterologist.
Pellish RS; Nasir A; Ramratnam B; Moss SF
Aliment Pharmacol Ther; 2008 May; 27(9):715-23. PubMed ID: 18248657
[TBL] [Abstract][Full Text] [Related]
33. Allele-specific RNA interference for neurological disease.
Rodriguez-Lebron E; Paulson HL
Gene Ther; 2006 Mar; 13(6):576-81. PubMed ID: 16355113
[TBL] [Abstract][Full Text] [Related]
34. SiLEncing SLE: the power and promise of small noncoding RNAs.
Rigby RJ; Vinuesa CG
Curr Opin Rheumatol; 2008 Sep; 20(5):526-31. PubMed ID: 18698172
[TBL] [Abstract][Full Text] [Related]
35. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
[TBL] [Abstract][Full Text] [Related]
36. Prospects of RNAi and microRNA-based therapies for hepatitis C.
Pan Q; Tilanus HW; Janssen HL; van der Laan LJ
Expert Opin Biol Ther; 2009 Jun; 9(6):713-24. PubMed ID: 19456206
[TBL] [Abstract][Full Text] [Related]
37. Unlocking the potential of the human genome with RNA interference.
Hannon GJ; Rossi JJ
Nature; 2004 Sep; 431(7006):371-8. PubMed ID: 15372045
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic gene silencing in the nervous system.
Wood MJ; Trülzsch B; Abdelgany A; Beeson D
Hum Mol Genet; 2003 Oct; 12 Spec No 2():R279-84. PubMed ID: 12928477
[TBL] [Abstract][Full Text] [Related]
39. From sequence to function: using RNAi to elucidate mechanisms of human disease.
Wolters NM; MacKeigan JP
Cell Death Differ; 2008 May; 15(5):809-19. PubMed ID: 18202701
[TBL] [Abstract][Full Text] [Related]
40. Small silencing RNAs: state-of-the-art.
Grimm D
Adv Drug Deliv Rev; 2009 Jul; 61(9):672-703. PubMed ID: 19427885
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
